Cite
MLA Citation
Mengmeng Yang et al.. “Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients1.” International journal of cancer, vol. 132, no. 2, n.d., pp. E74–E84. http://access.bl.uk/ark:/81055/vdc_100024515834.0x00003d